Pharmaceutical Business review

Alvine initiates Phase I trial for celiac disease treatment

Approximately 36 subjects are planned for enrollment in the trial to be conducted in the US. Both healthy human volunteers and subjects with celiac disease are expected to be dosed in this trial.